Psychedelics Today cover image

PT556 – The FDA, MDMA, and Public Perception: Was the FDA Fair to Lykos?, with Rick Doblin, Ph.D.

Psychedelics Today

00:00

Navigating MDMA Therapy Challenges

This chapter examines the criticisms and regulatory hurdles faced by Lycos in pursuing MDMA as a therapeutic treatment, particularly in relation to the FDA's scrutiny. It also highlights international initiatives aimed at providing trauma therapy in conflict-affected regions and discusses efforts to utilize MDMA therapy for rehabilitating released prisoners.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app